Treatment preferences of advanced ovarian cancer patients for adding bevacizumab to first-line therapy
详细信息 查看全文
- 作者：Jung-Yun Leea ; Kyunghoon Kimb ; Yun Shin Leec ; Hyo Young Kimc ; Eun Ji Nama ; Sunghoon Kima ; shkim70@yuhs.ac" class="auth_mail" title="E-mail the corresponding author ; Sang Wun Kima ; Jae Weon Kimd ; Young Tae Kima ; ytkchoi@yuhs.ac" class="auth_mail" title="E-mail the corresponding author
- 关键词：Ovarian cancer ; Bevacizumab ; Treatment preference ; Discrete choice experiment ; Trade-off question
- 刊名：Gynecologic Oncology
- 出版年：2016
- 出版时间：December 2016
- 年：2016
- 卷：143
- 期：3
- 页码：622-627
- 全文大小：650 K
文摘
- •
We explored patients' preferences for adding bevacizumab to first-line therapy.
- •
A discrete choice experiment and trade-off question were designed and distributed to ovarian cancer patients.
- •
Patients' preferences for bevacizumab depend primarily on drug costs.